Cholangiocarcinoma Clinical Trials

431 clinical trials for Cholangiocarcinoma across international registries, including 81 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers — RECRUITING · PHASE1
Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma — RECRUITING · PHASE2
A Study of PHST001 in Advanced Solid Tumors — RECRUITING · PHASE1
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies — RECRUITING · PHASE4
HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer — RECRUITING · NA
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer — RECRUITING
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors — RECRUITING · PHASE1
TCR1188-ABC Cells in KRAS-mutated Cancers — RECRUITING · PHASE1
On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver Cancer — RECRUITING
Ivosidenib in Locally Advanced or Metastatic Cholangiocarcinoma With IDH1 R132 Mutation After at Least One Prior Systemic Treatment - an Observational Study — RECRUITING
Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid — RECRUITING · NA
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS) — RECRUITING · NA
Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma — RECRUITING · PHASE1
PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma — RECRUITING · PHASE2
A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer — RECRUITING
An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer — RECRUITING
Targeted Navigation in Hepatocellular Carcinoma (HCC) — RECRUITING · NA
Evaluation of Skin Tests in Biotherapy Allergies — RECRUITING · NA
Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer — RECRUITING · PHASE1
Liver Cancer Registry Platform — RECRUITING
Trop2-targeted immunoPET Imaging of Solid Tumors — RECRUITING · PHASE2
TCF-001 TRACK (Target Rare Cancer Knowledge) Study — RECRUITING · NA
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection — RECRUITING · PHASE2
BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours — RECRUITING · PHASE1
Pemigatinib + Afatinib in Advanced Refractory Solid Tumors — RECRUITING · PHASE1
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors — RECRUITING · NA
Phase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP) — RECRUITING · PHASE2
Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma — RECRUITING · PHASE2
FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers — RECRUITING · PHASE2
In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers — RECRUITING
A Study of MGC028 in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio — RECRUITING · PHASE2
Molecular Epidemiology of Biliary Tree Cancers — RECRUITING
A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma — RECRUITING · PHASE2
Agnostic Therapy in Rare Solid Tumors — RECRUITING · PHASE2
Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab — RECRUITING
Liquid Biopsy MonitORing Of CholangioCarcinOma for Treatment Response and Prognostic Outcomes (MOROCCO) — RECRUITING
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome — RECRUITING
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers — RECRUITING · NA
Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer — RECRUITING · PHASE2
Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients — RECRUITING
Biobank for Cholestatic Liver Diseases. — RECRUITING
Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia — RECRUITING
PULSAR Combined With Immunotherapy and Chemotherapy — RECRUITING · PHASE1
Anti-PD-1/PD-L1 Antibodies Plus Gemcitabine and Cisplatin for Advanced CCA — RECRUITING
Diagnostic Approach for Cholangiocarcinoma Using Liquid Bile Biopsy — RECRUITING
Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer — RECRUITING · PHASE1
Mechanistic Study on the Protective and Regenerative Effects of Spirulina in Hepatectomy-Related Liver Injury — RECRUITING · NA
A Study of GV20-0251 in Advanced or Refractory Solid Tumors — RECRUITING · PHASE1
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry — RECRUITING

Refine this search